Brano Therapeutics
Latest round
- Seed
Last raised
- May 2026
Total raised
- $6.8M
Investors
- 4
About Brano Therapeutics
Founded in 2025 and headquartered in Singapore, Brano Therapeutics focuses on developing therapeutic solutions for heart failure conditions. The company has undergone no significant pivots in its business strategy and does not have any known subsidiaries. Its founder's history is not detailed in the available data.Brano Therapeutics specializes in the development of innovative therapeutic solutions aimed at addressing unmet medical needs in cardio-metabolic diseases, particularly focusing on Heart Failure with Preserved Ejection Fraction (HFpEF). The company’s primary product involves small-molecule inhibitors designed to restore disrupted metabolic pathways, ultimately aiming to improve patient outcomes for those suffering from HFpEF. This product is directed towards healthcare providers and institutions involved in cardiology and metabolic disease management.The revenue model of Brano Therapeutics is structured around partnerships and collaborations with healthcare institutions and pharmaceutical companies, focusing on the clinical development and commercialization of their therapeutic products. Revenue streams are expected to arise from licensing agreements, milestone payments, and potential royalties from successful product sales. The firm's flagship small-molecule inhibitors are positioned for B2B transactions, targeting hospitals and healthcare systems that integrate these therapies into their treatment protocols. The company is also looking to expand into markets across North America and Europe by the end of 2027, aligning its product development initiatives with the growing demand for innovative treatments in cardiology.
Who invested in Brano Therapeutics
4 investors across 1 round
See all investors in Brano Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 6, 2026
Amount
$6.8M
Investors
Questions about Brano Therapeutics
Who invested in Brano Therapeutics?
Brano Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brano Therapeutics raised?
Brano Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Brano Therapeutics last raise money?
Brano Therapeutics's most recent round on record is a Seed, in May 2026.
What does Brano Therapeutics do?
Founded in 2025 and headquartered in Singapore, Brano Therapeutics focuses on developing therapeutic solutions for heart failure conditions.
Where is Brano Therapeutics headquartered?
Brano Therapeutics is headquartered in Singapore, Singapore.
Which VCs invest in companies like Brano Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Brano Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Brano Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.